WO2021221149A1 - Oil-in-water emulsion composition - Google Patents
Oil-in-water emulsion composition Download PDFInfo
- Publication number
- WO2021221149A1 WO2021221149A1 PCT/JP2021/017143 JP2021017143W WO2021221149A1 WO 2021221149 A1 WO2021221149 A1 WO 2021221149A1 JP 2021017143 W JP2021017143 W JP 2021017143W WO 2021221149 A1 WO2021221149 A1 WO 2021221149A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oil
- water emulsified
- phase
- oil phase
- mass
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
Definitions
- the present invention relates to an oil-in-water emulsified composition. More specifically, the present invention relates to an oil-in-water emulsified composition having both an immediate visual skin correction effect and a long-term wrinkle improving effect by simultaneously blending an effective amount of powder and vitamins A (retinols).
- Vitamin A retinol
- vitamin A retinol
- retinol and its derivatives
- vitamin A acts on keratinocytes to exert a hyaluronic acid synthesis promoting effect and exerts a wrinkle improving effect by increasing the water content of the stratum corneum.
- vitamin As retinols
- vitamin As are extremely unstable and have a problem that they are easily altered by the influence of heat, light, oxygen and the like.
- Patent Document 1 describes an oil-in-water emulsified skin cosmetic containing vitamin A in combination with three types of nonionic surfactants and a higher alcohol having 14 to 24 carbon atoms.
- the nonionic surfactant and higher alcohol form an ⁇ -gel structure together with oil in the presence of water, stabilizing not only emulsion stability but also vitamin As. It is said that it can be held in.
- it is necessary to use all three types of specific nonionic surfactants, which narrows the range of formulations.
- Patent Document 2 states that (A) one or more higher alcohols having a linear saturated alkyl chain; (B) a hydrophilic surfactant containing a nonionic surfactant; (C) an average particle size. By containing 4 to 30% by mass of a powder of 1 to 30 ⁇ m; and (D) water, an aqueous cosmetic composition capable of naturally correcting the appearance of the skin while being an aqueous base having a fresh feeling of use. The thing is disclosed.
- Patent Document 3 describes (A) 1 to 20% by mass of hydrophobized titanium oxide having an average particle size of 0.1 ⁇ m or more; (B) a sugar ester having a carboxyl group in its structure; (C) a liquid higher fatty acid; The oil-in-water emulsified cosmetic containing (D) higher alcohol; (E) nonionic surfactant; (F) water and (G) oil has the effect of making the skin look beautiful and has emulsion stability. It is stated that it is excellent.
- Patent Documents 1 to 3 by introducing an ⁇ -gel structure into the system, it has succeeded in stably maintaining vitamin A in Patent Document 1 and powder components in Patent Documents 2 and 3. However, it has been difficult to exert the respective effects while keeping both the vitamin A and the powder stable by simply combining Patent Document 1 with Patent Document 2 or 3.
- the subject of the present invention is the effect of stably retaining vitamin A and powder components while utilizing the fresh feeling of use of the oil-in-water emulsified composition, the effect of immediately correcting the appearance of the skin, and wrinkles from a long-term perspective. It is an object of the present invention to provide an oil-in-water emulsified composition having an improving effect.
- an oil-in-water emulsified composition containing a first oil phase containing powder and a second oil phase containing vitamin A containing a first oil phase containing powder and a second oil phase containing vitamin A.
- the present invention is an oil-in-water emulsified composition in which an oil phase is dispersed in an aqueous phase, wherein the oil phase includes a first oil phase containing powder, vitamin A and / or a derivative thereof, and a polar oil.
- an oil-in-water emulsified composition comprising a second oil phase containing.
- the oil-in-water emulsified composition according to the present invention contains a powder component having a skin-correcting effect (unevenness-correcting effect) and vitamin A having a wrinkle-improving effect in separate oil phases, thereby mutually.
- the action can be suppressed.
- the oil-in-water emulsified cosmetic of the present invention is excellent in emulsification stability and can stably retain vitamin A having an effect of improving wrinkles for a long period of time and continuously exert its effect.
- composition of the present invention includes an aqueous phase which is a continuous phase and a first oil phase and a second oil phase which are dispersed phases. It will be described in detail below.
- the first oil phase in the composition of the present invention contains a powder and an oil component (also referred to as “first oil component”), and the powder is dispersed in the first oil component.
- the powder to be blended in the first oil phase is a powder that can be blended in cosmetics, external preparations for skin, etc., and is not particularly limited as long as it exhibits a skin correction effect (unevenness correction effect), and may be an inorganic powder. It may be an organic powder.
- the inorganic powder examples include titanium oxide, zinc oxide, talc, mica, sericite, kaolin, black iron oxide, yellow iron oxide, red iron oxide, carbon black, manganese violet, ultramarine blue, dark blue, chromium oxide, and the like.
- examples thereof include chromium hydroxide, calcium silicate, magnesium silicate, zinc oxide, calcium carbonate, magnesium carbonate, magnesium silicate, barium sulfate, and pearl pigments (bengala-coated mica, titanium oxide-coated mica, etc.).
- an ultraviolet scattering agent such as fine particle titanium oxide or fine particle zinc oxide having an average primary particle diameter of less than 100 ⁇ m.
- the surface of the inorganic powder particles is preferably hydrophobized.
- silicones such as methylhydrogenpolysiloxane and dimethylpolysiloxane, dextrin fatty acid ester, higher fatty acid, higher alcohol, fatty acid ester, metal soap, alkylphosphate ether, fluorine compound, or carbonization of squalane, paraffin and the like.
- methods for hydrophobizing treatment with hydrogens and the like by a wet method using a solvent, a vapor phase method, a mechanochemical method, or the like can be exemplified.
- the shape and size of the powder to be blended in the first oil phase are not particularly limited, but it is preferable to include the hydrophobic spherical powder in the blended powder because the skin correction effect is further improved.
- the hydrophobic spherical powder include silicone powder, resin powder such as PMMA, silica powder and the like.
- the amount of the powder to be blended in the first oil phase may be an amount that exerts a skin correction effect, and is usually 1% by mass or more, typically 3% by mass or more, based on the total amount of the composition.
- the upper limit of the blending amount of the powder is not particularly limited, but can be, for example, 20% by mass or less, 15% by mass or less, or the like with respect to the total amount of the composition.
- first oil As the oil contained in the first oil phase (also referred to as "first oil"), it is preferable to use a non-polar oil selected from hydrocarbon oil and silicone oil.
- silicone oil include chain polysiloxane (for example, dimethylpolysiloxane, methylphenylpolysiloxane, diphenylpolysiloxane, etc.); cyclic polysiloxane (for example, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexane). Siloxane, etc.).
- the amount of oil (first oil) to be blended in the first oil phase is usually 1 to 30% by mass, preferably 2 to 25% by mass, based on the total amount of the composition.
- the silicone oil occupies at least 40% by mass or more of the oil component (first oil component) constituting the first oil phase.
- the composition of the present invention includes, for example, an embodiment containing 50% by mass or more, 65% by mass or more, or 80% by mass or more of silicone oil of the first oil content. Alternatively, the entire first oil component may be used as silicone oil.
- Dispersants include higher fatty acids such as lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, undecylenic acid, tall acid, isostearic acid, linoleic acid, linolein. Acids, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and the like can be mentioned.
- EPA eicosapentaenoic acid
- DHA docosahexaenoic acid
- the first oil phase is preferably emulsified in the aqueous phase using a surfactant.
- a surfactant for emulsifying the first oil phase (referred to as "first surfactant"), it has a silicone-based surfactant, particularly a silicone skeleton (polysiloxane structure), and has an HLB of less than 8. It is preferable to use the above-mentioned surfactant.
- Silicone-based surfactants include, for example, polyoxyalkylene-modified silicones, polyoxyalkylene-alkyl co-modified silicones, polyglycerin-modified silicones, and / or polyglycerin-alkyl co-modified silicones.
- silicone-based surfactant used as the first surfactant include bisbutyldimethicone polyglyceryl-3, lauryl PEG-9 polydimethylsiloxyethyl dimethicone, PEG-9 polydimethylsiloxyethyl dimethicone, and PEG-.
- the first surfactant is preferably blended in an amount of 0.2 to 4% by mass based on the total amount of the composition.
- the second oil phase contains vitamin A and / or its derivatives and oils.
- the vitamin A fatty acid ester include retinol acetate, retinol palmitate, retinol propionate, and retinol linoleate.
- the salt examples include alkali metal salts (eg, sodium salt, potassium salt, lithium salt, etc.), alkaline earth metal salts (eg, calcium salt, magnesium salt, etc.), ammonium salts, organic amine salts (eg, monoethanolamine salt, etc.). , Diethanolamine salt, triethanolamine salt, etc.) and the like are exemplified.
- vitamin A retinol
- As the vitamin A and / or its derivative one kind or two or more kinds can be used.
- the blending amount of vitamin A and / or its derivative in the composition of the present invention is at least 0.01% by mass, preferably 0.05% by mass, based on the total amount of the composition. If the blending amount is less than 0.01% by mass, it is difficult to sufficiently exert the wrinkle improving effect. On the other hand, since a relatively large amount of vitamin A and / or a derivative thereof can be stably blended in the composition of the present invention, the upper limit of the blending amount is not particularly limited. For example, an upper limit value such as 10% by mass or less, 5% by mass or less, or 4% by mass or less can be set. That is, in the composition of the present invention, for example, a blending amount range of vitamin A and / or a derivative thereof such as 0.01 to 4% by mass or 0.05 to 5% by mass can be selected without limitation.
- the oil component to be blended in the second oil phase may contain polar oil as an essential component and may contain other oil components that can be blended in cosmetics and external preparations for skin. ..
- the polar oil is preferably selected from ester oils and UV absorbers. Examples of other oils include natural fats and oils, waxes and the like.
- ester oil examples include isopropyl myristate, cetyl octanoate, octyldodecyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, myristyl myristate, decyl oleate, hexyl decyl dimethyl octanate, and cetyl lactate.
- Myristyl Lactate Lanolin Acetate, Isocetyl Stearate, Isocetyl Isostearate, Cholesteryl 12-Hydroxystearate, Ethylene Glycol Di-2-ethylhexanoate, Dipentaerythritol Fatty Acid Ester, N-alkyl Glycol Monoisostearate, Neopentyl Glycol Dicaprate , Diisostearyl malate, Glycerin di-2-heptylundecanoate, Trimethylolpropane tri-2-ethylhexanoate, Trimethylolpropane triisostearate, Pentaerislit tetra-2-ethylhexanoate, Tri-2-ethyl Glycerin hexanoate, glycerin trioctanoate, glycerin triisopalmitate, cetyl 2-ethylhexanoate, 2-ethylhex
- an oil-soluble ultraviolet absorber can be blended in place of the above ester oil or in addition to the ester oil.
- the oil-soluble UV absorber those that can be usually used for cosmetics and external skin preparations can be used.
- triazine-based UV absorbers benzoic acid-based UV absorbers, anthranilic acid-based UV absorbers, and salicylic acid. Examples thereof include UV absorbers, silicic acid UV absorbers, and benzophenone UV absorbers.
- 2-ethylhexyl paramethoxycinnamate which is an ultraviolet absorber that is liquid at room temperature, is preferably used.
- the blending amount of the oil component (second oil component) in the second oil phase is 5 to 40% by mass with respect to the total amount of the composition.
- the second oil preferably contains polar oil.
- the blending amount of the polar oil is preferably 1 to 35% by mass, more preferably 10 to 30% by mass, based on the total amount of the composition.
- the ratio (mass%) of the polar oil to the total amount of the second oil phase is preferably 15% by mass or more, more preferably 30% by mass or more, and further preferably 45% by mass or more.
- the polar oil preferably contains an ester oil, and the ratio (mass%) of the ester oil to the total amount of the polar oil is preferably 50% by mass or more, more preferably 60% by mass or more. be.
- the second oil phase preferably contains a higher alcohol and / or a higher fatty acid (hereinafter also referred to as “higher alcohol or the like”) and a surfactant (referred to as “second surfactant").
- Examples of the higher alcohol to be blended in the second oil phase include dodecanol (lauryl alcohol), tridodecanol, tetradodecanol (myristyl alcohol), pentadecanol, hexadecanol (cetyl alcohol), heptadecanol, and the like.
- Octadecanol (stearyl alcohol), nonadecanol, icosanol (araquil alcohol), henicosanol, docosanol (behenyl alcohol), tricosanol, tetracosanol (carnavir alcohol), pentacosanol, hexacosanol (ceryl alcohol), bacil alcohol, Elysyl alcohol and the like can be mentioned.
- the higher alcohol etc.
- one or more of the above can be used.
- the combination is such that the melting point of the mixture is 60 ° C. or higher. If this melting point is less than 60 ° C., the temperature stability of the system may decrease depending on the formulation.
- a combination of stearyl alcohol, behenyl alcohol and batyl alcohol is particularly preferable.
- the blending amount of the higher alcohol or the like in the cosmetic composition of the present invention is not particularly limited, but is 0.3 to 10% by mass, preferably 0.5 to 9% by mass.
- a nonionic surfactant is preferable.
- Specific examples include glycerin monostearyl ether, POE (20) cetyl ether, POE (30) cetyl ether, POE (20) stearyl ether, POE (25) stearyl ether, POE (30) stearyl ether, POE (20) behenyl.
- POE (20) cetyl ether, POE (30) cetyl ether, POE (20) stearyl ether, POE (30) stearyl ether, POE (30) behenyl ether and the like can be mentioned.
- POE is an abbreviation for polyoxyethylene.
- the blending amount of the second surfactant is preferably 0.3 to 10% by mass, more preferably 0.5 to 5% by mass, based on the total amount of the composition.
- the higher alcohol or the like By blending a higher alcohol or the like and a second surfactant in the second oil phase, the higher alcohol or the like forms an aggregate composed of a lamellar bilayer film together with the second surfactant in the presence of water.
- the higher alcohol or the like can take a so-called ⁇ -gel structure and contributes to the stabilization of the system.
- composition of the present invention is described in Patent Document 1 because it is stabilized by blending powder in the first oil phase and blending a polar oil such as an ultraviolet absorber in the second oil phase. It is not necessary to use a combination of three specific surfactants as described above. Therefore, the composition of the present invention does not contain any one or more of sorbitan tristearate, polyethylene glycol stearate having an addition molar number of 20 to 120, and glyceryl stearate having an HLB of 5 to 8. Includes aspects.
- the composition of the present invention is an oil-in-water emulsified composition in which the above-mentioned first oil phase and second oil phase are dispersed in an aqueous phase.
- the aqueous phase which is a continuous phase in the emulsified composition of the present invention, contains water and optionally contains an aqueous component.
- Aqueous components are components that are soluble or compatible with water.
- a surfactant By blending a surfactant (referred to as “third surfactant”) in the aqueous phase, the stability of the emulsification system is further improved.
- the third surfactant it is preferable to select a nonionic hydrophilic surfactant having a relatively bulky molecular structure.
- polyoxyethylene hydrogenated castor oil (10EO), polyoxyethylene hydrogenated castor oil (20EO), polyoxyethylene hydrogenated castor oil (30EO), polyoxyethylene hydrogenated Poly such as castor oil (40EO), polyoxyethylene hydrogenated castor oil (50EO), polyoxyethylene hydrogenated castor oil (60EO), polyoxyethylene hydrogenated castor oil (100EO), etc.
- At least one nonionic selected from the group consisting of oxyethylene hydrogenated castor oil, polyoxyethylene glyceryl stearate, polyoxyethylene glyceryl isostearate, polyoxyethylene glyceryl triisostearate, and polyoxyethylene hydrogenated castor oil succinic acid.
- a surfactant is preferably used.
- the blending amount of the third surfactant in the composition of the present invention is preferably 0.3 to 10% by mass, preferably in the range of 0.5 to 9% by mass, based on the total amount of the composition. More preferred.
- a thickener to the aqueous phase because the emulsification stability can be further improved by suppressing the sedimentation and creaming of the emulsified oil droplets and the aggregation of the powder over time.
- the thickener to be blended in the aqueous phase is not particularly limited as long as it is an aqueous phase thickener that can be used in cosmetics and quasi-drugs.
- xanthan gum cellulose (carboxymethyl cellulose (salt), etc.), Arabic gum, carrageenan, pectin, canten, quince seed (malmero) extract, starch, algae colloid (brown algae extract), mucopolysaccharide, white jellyfish polysaccharide, succinoglycan.
- Plant-based polymers such as dextran and purulan, animal-based polymers such as collagen, casein and gelatin, starch-based polymers such as carboxymethyl starch and methylhydroxypropyl starch, (Na acrylate, acryloyl).
- starch-based polymers such as carboxymethyl starch and methylhydroxypropyl starch, (Na acrylate, acryloyl).
- acrylic acid-based polymers such as dimethyl taurine Na) copolymers, (dimethyl acrylamide / acryloyl dimethyl taurine Na) cross polymers, and copolymers containing 2-acrylamide-2-methylpropansulfonic acid.
- the amount of the thickener to be blended is preferably 0.1 to 6% by mass with respect to the total amount of the composition.
- the silicone elastomer powder When the silicone elastomer powder is blended with the composition of the present invention, stickiness can be suppressed and the usability of the composition can be further improved.
- a spherical powder of a silicone elastomer particularly a white spherical silicone composite powder in which a spherical silicone rubber powder is coated with a silicone resin.
- the average particle size of the silicone elastomer spherical powder is preferably 0.1 to 100 ⁇ m, more preferably 1 to 50 ⁇ m, and the JIS-A hardness is preferably in the range of 10 to 80.
- silicone elastomer powder examples include (vinyldimethicone / methicone silsesquioxane) crosspolymer, (diphenyldimethicone / vinyldiphenyldimethicone / silsesquioxane) crosspolymer, and polysilicone-in the cosmetic ingredient labeling name.
- One or more selected from 1 cross polymer, polysilicone-22, (dimethicone / vinyldimethicone / methicone) cross polymer and the like are preferably used.
- the blending amount of the silicone elastomer powder is preferably 1 to 10% by mass, more preferably 2 to 8% by mass.
- the silicone elastomer powder may be blended in either the oil phase or the aqueous phase, but is preferably blended in the aqueous phase.
- composition of the present invention can be added with various ingredients widely used in cosmetics and quasi-drugs as long as the effects of the present invention are not impaired.
- water-soluble active substances or stabilizers such as vitamin B group, vitamin C and its derivatives, potassium 4-methoxysalicylate, tranexamic acid, pantothenic acid and its derivatives, vitamins such as biotin, moisturizers, vitamin E, arginine.
- the method for producing the composition of the present invention is not particularly limited, but for example, an oil-in-water emulsion (referred to as "first emulsion") in which the first oil phase component is dispersed in a part of the aqueous phase is prepared. Then, an oil-in-water emulsion (referred to as “second emulsion”) in which the second oil phase component is dispersed in the remaining aqueous phase is separately prepared, and then the first emulsion and the second emulsion are prepared. Can be manufactured by mixing with. Alternatively, it can also be produced by preparing a first emulsion in which the first oil phase component is dispersed in an aqueous phase, and then adding a second oil phase component to the first emulsion and emulsifying it.
- first emulsion oil-in-water emulsion
- second emulsion oil-in-water emulsion
- it can also be produced by preparing a first emulsion in which the first oil phase component
- composition of the present invention not only exerts a skin-correcting effect immediately after application while having a fresh feel peculiar to an oil-in-water emulsion, but also has a long-term wrinkle improving effect due to the blended vitamin As. Demonstrate over.
- the present invention provides an oil-in-water emulsified cosmetic, particularly a skin cosmetic, comprising the composition of the present invention described above.
- the form of the oil-in-water emulsified cosmetic of the present invention is not particularly limited, and can be provided in various forms such as cream, milky lotion, or gel.
- An oil-in-water emulsified composition was prepared according to the formulations listed in Tables 1 and 2 below.
- the composition of each example was produced as follows. (1) Prepare an aqueous phase. (2) A first oil phase (oil phase 1) that has been subjected to a dispersion treatment is prepared. (3) The first oil phase is mixed with the aqueous phase to prepare a first emulsion. (4) The second oil phase component (oil phase 2) is heated and mixed to prepare a second oil phase. (5) The second oil phase is mixed with the first emulsion and cooled to room temperature.
- ⁇ Skin correction effect> The composition of each example (immediately after production) was applied to the face by a specialized panel (10 people), and the actual feeling of the effect was evaluated for the skin correction effect after application according to the following criteria.
- D 3 or less evaluated that "there is a real feeling of effect”.
- ⁇ Wrinkle improvement effect> The compositions of each example were shielded from light with aluminum foil and stored at 50 ° C. for 1 month.
- the amount of vitamin A in the composition after 1 month (50 ° C.) was analyzed by high performance liquid chromatography, and the residual ratio (%) with respect to the amount of vitamin A immediately after production was calculated. The higher the residual rate, the more the activity of vitamin A is maintained and the effect of improving wrinkles is exhibited.
- the conditions of high performance liquid chromatography used are as follows. Column: C18 column (manufactured by Shiseido Co., Ltd.) Detection: UV310nm Mobile phase: 72% ethanol / 10% acetonitrile / 17.5% ion-exchanged water / 0.5% acetic acid
- Residual rate is 90% or more
- B Residual rate is 80% or more and less than 90%
- C Residual rate is 60% or more and less than 80%
- D Residual rate is less than 60%
- the compositions of the present invention in which the powder was blended in the first oil phase and vitamin A was blended in the second oil phase had emulsion stability. Good results were obtained in all of the skin correction effect and the wrinkle improvement effect. These good results show that the amount of vitamin A in the second oil phase is increased (implementation) regardless of the type and amount of the thickener to be blended in the aqueous phase, or the presence or absence of the silicone elastomer powder (Examples 1 to 3). It does not depend on Example 4) or the type of oil in the first oil phase (Example 5).
- Example 6 when the ratio of the polar oil in the second oil phase was lowered, the wrinkle improving effect was slightly reduced, but there was no problem in practical use (Example 6).
- the composition of Example 6 was separated under severe conditions of storage at 50 ° C. for 1 month, but was stable for more than 1 month when stored at the actual operating temperature (room temperature).
- the skin correction effect was not obtained in Comparative Example 1 in which the powder was not blended with respect to these Examples.
- Comparative Example 2 in which the powder and vitamin A were blended in the same oil phase, vitamin A could not be stably retained, and a sufficient wrinkle improving effect could not be obtained.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
[Problem] To provide an oil-in-water emulsion composition that stably maintains vitamin A and the like and powder components while utilizing the moisturizing feeling inherent to oil-in-water emulsion compositions, and that has both the effect of instantaneously correcting the appearance of the skin and the effect of improving wrinkles from a long-term perspective. [Solution] An oil-in-water emulsion composition in which an oil phase is dispersed in an aqueous phase, and which is characterized in that the oil phase includes a first oil phase containing a powder, and a second oil phase containing a polar oil and vitamin A and/or a derivative thereof.
Description
本発明は水中油型乳化組成物に関する。より詳しくは、粉末とビタミンA類(レチノール類)とを同時に有効量配合することにより、即座の視覚的な肌補正効果と長期的なしわ改善効果とを併せ持つ水中油型乳化組成物に関する。
The present invention relates to an oil-in-water emulsified composition. More specifically, the present invention relates to an oil-in-water emulsified composition having both an immediate visual skin correction effect and a long-term wrinkle improving effect by simultaneously blending an effective amount of powder and vitamins A (retinols).
皮膚のしわ改善効果を有する化粧品成分としてビタミンA(レチノール)及びその誘導体(「ビタミンA類」又は「レチノール類」という)が知られ、ビタミンA類を配合した各種化粧料が製造されている。ビタミンA類は、ケラチノサイトに作用してヒアルロン酸合成促進効果を発現し、角質層水分を増加する効果により、シワ改善効果を発揮することが知られている。しかし、ビタミンA類(レチノール類)は非常に不安定であり、熱、光、酸素等の影響を受けて容易に変質するという問題がある。
Vitamin A (retinol) and its derivatives (referred to as "vitamin A" or "retinol") are known as cosmetic ingredients having an effect of improving skin wrinkles, and various cosmetics containing vitamin A are manufactured. It is known that vitamin A acts on keratinocytes to exert a hyaluronic acid synthesis promoting effect and exerts a wrinkle improving effect by increasing the water content of the stratum corneum. However, vitamin As (retinols) are extremely unstable and have a problem that they are easily altered by the influence of heat, light, oxygen and the like.
特許文献1には、ビタミンA類を、3種類の非イオン性界面活性剤と炭素原子数が14~24の高級アルコールとを組み合わせて配合した水中油型乳化皮膚化粧料が記載されている。特許文献1の皮膚化粧料においては、前記の非イオン性界面活性剤と高級アルコールが、水の存在下で、油分とともにαゲル構造を形成し、乳化安定性のみならず、ビタミンA類を安定に保持できるとされている。しかしながら、安定化効果を得るためには、3種類の特定の非イオン性界面活性剤を全て用いる必要があり処方の幅が狭められていた。
Patent Document 1 describes an oil-in-water emulsified skin cosmetic containing vitamin A in combination with three types of nonionic surfactants and a higher alcohol having 14 to 24 carbon atoms. In the skin cosmetics of Patent Document 1, the nonionic surfactant and higher alcohol form an α-gel structure together with oil in the presence of water, stabilizing not only emulsion stability but also vitamin As. It is said that it can be held in. However, in order to obtain the stabilizing effect, it is necessary to use all three types of specific nonionic surfactants, which narrows the range of formulations.
一方、粉末成分による光拡散効果によって、しわ等の肌の凹凸を目立ちにくくする効果(「肌補正効果」又は「凹凸補正効果」)を有する化粧料も知られているが、特に水中油型乳化化粧料に粉末を配合する場合には、乳化安定性の低下や粉末の凝集が問題になることがあった。
On the other hand, cosmetics having an effect of making unevenness of the skin such as wrinkles less noticeable (“skin correction effect” or “unevenness correction effect”) by the light diffusion effect of the powder component are also known, but in particular, oil-in-water emulsification When powder is added to cosmetics, deterioration of emulsion stability and aggregation of powder may be a problem.
特許文献2には、(A)直鎖飽和アルキル鎖を有する高級アルコールの1種または2種以上;(B)非イオン性界面活性剤を含む親水性界面活性剤;(C)平均粒径が1~30μmの粉末を4~30質量%;及び(D)水を含有することにより、みずみずしい使用感触を有する水性基剤でありながら、肌の見た目を自然に補正することのできる水性化粧料組成物が開示されている。
Patent Document 2 states that (A) one or more higher alcohols having a linear saturated alkyl chain; (B) a hydrophilic surfactant containing a nonionic surfactant; (C) an average particle size. By containing 4 to 30% by mass of a powder of 1 to 30 μm; and (D) water, an aqueous cosmetic composition capable of naturally correcting the appearance of the skin while being an aqueous base having a fresh feeling of use. The thing is disclosed.
特許文献3には、(A)平均粒子径が0.1μm以上の疎水化処理酸化チタンを1~20質量%;(B)カルボキシル基を構造中に有する糖エステル;(C)液状高級脂肪酸;(D)高級アルコール;(E)非イオン性界面活性剤;(F)水、及び(G)油分を含有する水中油型乳化化粧料が、肌をきれいに見せる効果を有し、なおかつ乳化安定性に優れると記載されている。
Patent Document 3 describes (A) 1 to 20% by mass of hydrophobized titanium oxide having an average particle size of 0.1 μm or more; (B) a sugar ester having a carboxyl group in its structure; (C) a liquid higher fatty acid; The oil-in-water emulsified cosmetic containing (D) higher alcohol; (E) nonionic surfactant; (F) water and (G) oil has the effect of making the skin look beautiful and has emulsion stability. It is stated that it is excellent.
特許文献1~3では、系にαゲル構造を導入することにより、特許文献1ではビタミンA類、特許文献2及び3では粉末成分を安定に維持することに成功している。しかしながら、特許文献1に特許文献2又は3を単純に組み合わせたのみでは、ビタミンA類と粉末の両方を安定に保ちながら各々の効果を発揮させることは困難であった。
In Patent Documents 1 to 3, by introducing an α-gel structure into the system, it has succeeded in stably maintaining vitamin A in Patent Document 1 and powder components in Patent Documents 2 and 3. However, it has been difficult to exert the respective effects while keeping both the vitamin A and the powder stable by simply combining Patent Document 1 with Patent Document 2 or 3.
よって本発明における課題は、水中油型乳化組成物のみずみずしい使用感を活かしつつ、ビタミンA類と粉末成分を安定に保持し、肌の見た目を即時に補正する効果と長期的な視点でのしわ改善効果とを併せ持つ水中油型乳化組成物を提供することである。
Therefore, the subject of the present invention is the effect of stably retaining vitamin A and powder components while utilizing the fresh feeling of use of the oil-in-water emulsified composition, the effect of immediately correcting the appearance of the skin, and wrinkles from a long-term perspective. It is an object of the present invention to provide an oil-in-water emulsified composition having an improving effect.
本発明者等は、前記課題を解決するために鋭意検討を重ねた結果、粉末を含む第1の油相と、ビタミンA類を含む第2の油相とを含む水中油型乳化組成物とすることにより、即効的な肌の視覚的補正効果と長期的な視点でのしわ改善効果とを両立し、さらに安定性にも優れた水中油型乳化組成物が得られることを見出し、本発明を完成するに至った。
As a result of diligent studies to solve the above problems, the present inventors have obtained an oil-in-water emulsified composition containing a first oil phase containing powder and a second oil phase containing vitamin A. By doing so, it has been found that an oil-in-water emulsified composition having both an immediate effect of visually correcting the skin and an effect of improving wrinkles from a long-term perspective and also having excellent stability can be obtained. Has been completed.
すなわち、本発明は、水相中に油相が分散した水中油型乳化組成物であって、前記油相が、粉末を含む第1の油相と、ビタミンA及び/又はその誘導体及び極性油を含む第2の油相とを含むことを特徴とする、水中油型乳化組成物を提供する。
That is, the present invention is an oil-in-water emulsified composition in which an oil phase is dispersed in an aqueous phase, wherein the oil phase includes a first oil phase containing powder, vitamin A and / or a derivative thereof, and a polar oil. Provided is an oil-in-water emulsified composition comprising a second oil phase containing.
本発明に係る水中油型乳化組成物は、肌補正効果(凹凸補正効果)を持つ粉末成分と、しわ改善効果を持つビタミンA類を、各々別々の油相に含有せしめることにより両者間の相互作用を抑制することができる。その結果、即効性のある肌補正効果と長期に亘るしわ改善効果とを両立できる。なおかつ、本発明の水中油型乳化化粧料は、乳化安定性に優れ、シワ改善効果を持つビタミンA類を長期間安定に保持して効果を持続的に発揮することができる。
The oil-in-water emulsified composition according to the present invention contains a powder component having a skin-correcting effect (unevenness-correcting effect) and vitamin A having a wrinkle-improving effect in separate oil phases, thereby mutually. The action can be suppressed. As a result, it is possible to achieve both an immediate skin correction effect and a long-term wrinkle improvement effect. Moreover, the oil-in-water emulsified cosmetic of the present invention is excellent in emulsification stability and can stably retain vitamin A having an effect of improving wrinkles for a long period of time and continuously exert its effect.
本発明の水中油型乳化組成物(以下「本発明の組成物」ともいう)は、連続相である水相と、分散相である第1の油相及び第2の油相とを含む。以下に詳述する。
The oil-in-water emulsified composition of the present invention (hereinafter, also referred to as "composition of the present invention") includes an aqueous phase which is a continuous phase and a first oil phase and a second oil phase which are dispersed phases. It will be described in detail below.
<第1の油相>
本発明の組成物における第1の油相は、粉末及び油分(「第1の油分」ともいう)を含有し、前記の粉末は第1の油分中に分散されている。 <First oil phase>
The first oil phase in the composition of the present invention contains a powder and an oil component (also referred to as "first oil component"), and the powder is dispersed in the first oil component.
本発明の組成物における第1の油相は、粉末及び油分(「第1の油分」ともいう)を含有し、前記の粉末は第1の油分中に分散されている。 <First oil phase>
The first oil phase in the composition of the present invention contains a powder and an oil component (also referred to as "first oil component"), and the powder is dispersed in the first oil component.
第1の油相に配合する粉末は、化粧料や皮膚外用剤等に配合可能な粉末であって、肌補正効果(凹凸補正効果)を発揮するものであれば特に限定されず、無機粉末でも有機粉末でもよい。
The powder to be blended in the first oil phase is a powder that can be blended in cosmetics, external preparations for skin, etc., and is not particularly limited as long as it exhibits a skin correction effect (unevenness correction effect), and may be an inorganic powder. It may be an organic powder.
無機粉末としては、例えば、酸化チタン、酸化亜鉛、タルク、マイカ、セリサイト、カオリン、黒酸化鉄、黄酸化鉄、ベンガラ(赤酸化鉄)、カーボンブラック、マンガンバイオレット、群青、紺青、酸化クロム、水酸化クロム、珪酸カルシウム、珪酸マグネシウム、酸化ジルコニウム、炭酸カルシウム、炭酸マグネシウム、ケイ酸マグネシウム、硫酸バリウム、パール顔料(ベンガラ被覆雲母、酸化チタン被覆雲母等)等が挙げられる。本発明の組成物を日焼け止め化粧料とする場合には、平均一次粒子径が100μm未満の微粒子酸化チタンや微粒子酸化亜鉛などの紫外線散乱剤を用いることが好ましい。
Examples of the inorganic powder include titanium oxide, zinc oxide, talc, mica, sericite, kaolin, black iron oxide, yellow iron oxide, red iron oxide, carbon black, manganese violet, ultramarine blue, dark blue, chromium oxide, and the like. Examples thereof include chromium hydroxide, calcium silicate, magnesium silicate, zinc oxide, calcium carbonate, magnesium carbonate, magnesium silicate, barium sulfate, and pearl pigments (bengala-coated mica, titanium oxide-coated mica, etc.). When the composition of the present invention is used as a sunscreen cosmetic, it is preferable to use an ultraviolet scattering agent such as fine particle titanium oxide or fine particle zinc oxide having an average primary particle diameter of less than 100 μm.
無機粉末の粒子は、表面を疎水化処理したものが好ましい。表面処理としては、メチルハイドロジェンポリシロキサン、ジメチルポリシロキサン等のシリコーン類、デキストリン脂肪酸エステル、高級脂肪酸、高級アルコール、脂肪酸エステル、金属石鹸、アルキルリン酸エーテル、フッ素化合物、またはスクワラン、パラフィン等の炭化水素類などで、溶媒を使用する湿式法、気相法、メカノケミカル法等により疎水化処理する方法が例示できる。
The surface of the inorganic powder particles is preferably hydrophobized. As the surface treatment, silicones such as methylhydrogenpolysiloxane and dimethylpolysiloxane, dextrin fatty acid ester, higher fatty acid, higher alcohol, fatty acid ester, metal soap, alkylphosphate ether, fluorine compound, or carbonization of squalane, paraffin and the like. Examples of methods for hydrophobizing treatment with hydrogens and the like by a wet method using a solvent, a vapor phase method, a mechanochemical method, or the like can be exemplified.
第1の油相に配合する粉末の形状及び大きさは特に限定されないが、配合する粉末に疎水性球状粉末を含めることにより、肌補正効果が更に向上するので好ましい。疎水性球状粉末の例としては、シリコーン粉末,PMMA等の樹脂粉末、シリカ粉末等が挙げられる。
The shape and size of the powder to be blended in the first oil phase are not particularly limited, but it is preferable to include the hydrophobic spherical powder in the blended powder because the skin correction effect is further improved. Examples of the hydrophobic spherical powder include silicone powder, resin powder such as PMMA, silica powder and the like.
第1の油相に配合する粉末の配合量は、肌補正効果を発揮する量であればよく、通常は、組成物全量に対して1質量%以上、典型的には3質量%以上配合される。粉末の配合量の上限値は特に限定されないが、例えば組成物全量に対して20質量%以下、あるいは15質量%以下等とすることができる。
The amount of the powder to be blended in the first oil phase may be an amount that exerts a skin correction effect, and is usually 1% by mass or more, typically 3% by mass or more, based on the total amount of the composition. NS. The upper limit of the blending amount of the powder is not particularly limited, but can be, for example, 20% by mass or less, 15% by mass or less, or the like with respect to the total amount of the composition.
第1の油相に含まれる油分(「第1の油分」ともいう)は、炭化水素油及びシリコーン油から選択される非極性油を用いるのが好ましい。シリコーン油としては、例えば、鎖状ポリシロキサン(例えば、ジメチルポリシロキサン、メチルフェニルポリシロキサン、ジフェニルポリシロキサン等);環状ポリシロキサン(例えば、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサシロキサン等)が挙げられる。
As the oil contained in the first oil phase (also referred to as "first oil"), it is preferable to use a non-polar oil selected from hydrocarbon oil and silicone oil. Examples of the silicone oil include chain polysiloxane (for example, dimethylpolysiloxane, methylphenylpolysiloxane, diphenylpolysiloxane, etc.); cyclic polysiloxane (for example, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexane). Siloxane, etc.).
第1の油相に配合する油分(第1の油分)の量は、通常は組成物全量に対して1~30質量%、好ましくは2~25質量%である。特に、第1の油相を構成する油分(第1の油分)の少なくとも40質量%以上をシリコーン油が占めるようにするのが好ましい。本発明の組成物は、例えば、第1の油分の50質量%以上、65質量%以上、又は80質量%以上のシリコーン油を含有する態様を含む。あるいは、第1の油分の全部をシリコーン油としてもよい。
The amount of oil (first oil) to be blended in the first oil phase is usually 1 to 30% by mass, preferably 2 to 25% by mass, based on the total amount of the composition. In particular, it is preferable that the silicone oil occupies at least 40% by mass or more of the oil component (first oil component) constituting the first oil phase. The composition of the present invention includes, for example, an embodiment containing 50% by mass or more, 65% by mass or more, or 80% by mass or more of silicone oil of the first oil content. Alternatively, the entire first oil component may be used as silicone oil.
第1の油相においては、分散剤を用いて油分中に前記の粉末を分散させるのが好ましい。分散剤(「粉末分散剤」ともいう)としては、高級脂肪酸、例えば、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、オレイン酸、ウンデシレン酸、トール酸、イソステアリン酸、リノール酸、リノレイン酸、エイコサペンタエン酸(EPA)、ドコサヘキサエン酸(DHA)等が挙げられる。
In the first oil phase, it is preferable to disperse the powder in the oil using a dispersant. Dispersants (also referred to as "powder dispersants") include higher fatty acids such as lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, undecylenic acid, tall acid, isostearic acid, linoleic acid, linolein. Acids, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and the like can be mentioned.
第1の油相は、界面活性剤を用いて水相中に乳化するのが好ましい。第1の油相を乳化するための界面活性剤(「第1の界面活性剤」という)としては、シリコーン系界面活性剤、特に、シリコーン骨格(ポリシロキサン構造)を有し、HLBが8未満の界面活性剤を用いるのが好ましい。シリコーン系界面活性剤には、例えば、ポリオキシアルキレン変性シリコーン、ポリオキシアルキレン・アルキル共変性シリコーン、ポリグリセリン変性シリコーン、及び/又はポリグリセリン・アルキル共変性シリコーン等が含まれる。
The first oil phase is preferably emulsified in the aqueous phase using a surfactant. As a surfactant for emulsifying the first oil phase (referred to as "first surfactant"), it has a silicone-based surfactant, particularly a silicone skeleton (polysiloxane structure), and has an HLB of less than 8. It is preferable to use the above-mentioned surfactant. Silicone-based surfactants include, for example, polyoxyalkylene-modified silicones, polyoxyalkylene-alkyl co-modified silicones, polyglycerin-modified silicones, and / or polyglycerin-alkyl co-modified silicones.
第1の界面活性剤として使用される、シリコーン系界面活性剤の具体例としては、ビスブチルジメチコンポリグリセリル-3、ラウリルPEG-9ポリジメチルシロキシエチルジメチコン、PEG-9ポリジメチルシロキシエチルジメチコン、PEG-10ジメチコン、ビスブチルジメチコンポリグリセリル-3、セチルPEG/PPG-10/1ジメチコン、PEG-12ジメチコン、(ジメチコン/(PEG-10/15))クロスポリマー、(ジメチコン/ポリグリセリン-3)クロスポリマー、(PEG-15/ラウリルポリジメチルシロキシエチルジメチコン)クロスポリマー、(アクリル酸/メタクリル酸ステアリル/メタクリ酸ジメチコン)コポリマー、アモジメチコン等を挙げることができる。
Specific examples of the silicone-based surfactant used as the first surfactant include bisbutyldimethicone polyglyceryl-3, lauryl PEG-9 polydimethylsiloxyethyl dimethicone, PEG-9 polydimethylsiloxyethyl dimethicone, and PEG-. 10 Dimethicone, Bisbutyl Dimethicone Polyglyceryl-3, Cetyl PEG / PPG-10 / 1 Dimethicone, PEG-12 Dimethicone, (Dimethicone / (PEG-10 / 15)) Crosspolymer, (Dimethicone / Polyglycerin-3) Crosspolymer, Examples thereof include (PEG-15 / laurylpolydimethylsiloxyethyl dimethicone) crosspolymer, (acrylic acid / stearyl methacrylate / dimethicone methacrylate) copolymer, amodimethicone and the like.
第1の界面活性剤は、乳化安定性という観点から、組成物全量に対して、0.2~4質量%配合するのが好ましい。
From the viewpoint of emulsion stability, the first surfactant is preferably blended in an amount of 0.2 to 4% by mass based on the total amount of the composition.
<第2の油相>
第2の油相は、ビタミンA及び/又はその誘導体及び油分を含有する。
ビタミンA及び/又はその誘導体としては、例えば、ビタミンA(=レチノール)、ビタミンAアルデヒド(=レチナール)、ビタミンA酸(=レチノイン酸)、ビタミンA脂肪酸エステルや、それらの塩などが挙げられる。ビタミンA脂肪酸エステルとしては、酢酸レチノール、パルミチン酸レチノール、プロピオン酸レチノール、リノール酸レチノール等が例示される。塩としては、アルカリ金属塩(例えば、ナトリウム塩、カリウム塩、リチウム塩など)、アルカリ土類金属塩(例えば、カルシウム塩、マグネシウム塩など)、アンモニウム塩、有機アミン塩(例えば、モノエタノールアミン塩、ジエタノールアミン塩、トリエタノールアミン塩など)等が例示される。本発明では、安定性、有効性等の点から、特にビタミンA(レチノール)が好ましく用いられる。上記ビタミンA及び/又はその誘導体は1種または2種以上を用いることができる。 <Second oil phase>
The second oil phase contains vitamin A and / or its derivatives and oils.
Examples of vitamin A and / or its derivatives include vitamin A (= retinol), vitamin A aldehyde (= retinal), vitamin A acid (= retinoic acid), vitamin A fatty acid ester, and salts thereof. Examples of the vitamin A fatty acid ester include retinol acetate, retinol palmitate, retinol propionate, and retinol linoleate. Examples of the salt include alkali metal salts (eg, sodium salt, potassium salt, lithium salt, etc.), alkaline earth metal salts (eg, calcium salt, magnesium salt, etc.), ammonium salts, organic amine salts (eg, monoethanolamine salt, etc.). , Diethanolamine salt, triethanolamine salt, etc.) and the like are exemplified. In the present invention, vitamin A (retinol) is particularly preferably used from the viewpoint of stability, effectiveness and the like. As the vitamin A and / or its derivative, one kind or two or more kinds can be used.
第2の油相は、ビタミンA及び/又はその誘導体及び油分を含有する。
ビタミンA及び/又はその誘導体としては、例えば、ビタミンA(=レチノール)、ビタミンAアルデヒド(=レチナール)、ビタミンA酸(=レチノイン酸)、ビタミンA脂肪酸エステルや、それらの塩などが挙げられる。ビタミンA脂肪酸エステルとしては、酢酸レチノール、パルミチン酸レチノール、プロピオン酸レチノール、リノール酸レチノール等が例示される。塩としては、アルカリ金属塩(例えば、ナトリウム塩、カリウム塩、リチウム塩など)、アルカリ土類金属塩(例えば、カルシウム塩、マグネシウム塩など)、アンモニウム塩、有機アミン塩(例えば、モノエタノールアミン塩、ジエタノールアミン塩、トリエタノールアミン塩など)等が例示される。本発明では、安定性、有効性等の点から、特にビタミンA(レチノール)が好ましく用いられる。上記ビタミンA及び/又はその誘導体は1種または2種以上を用いることができる。 <Second oil phase>
The second oil phase contains vitamin A and / or its derivatives and oils.
Examples of vitamin A and / or its derivatives include vitamin A (= retinol), vitamin A aldehyde (= retinal), vitamin A acid (= retinoic acid), vitamin A fatty acid ester, and salts thereof. Examples of the vitamin A fatty acid ester include retinol acetate, retinol palmitate, retinol propionate, and retinol linoleate. Examples of the salt include alkali metal salts (eg, sodium salt, potassium salt, lithium salt, etc.), alkaline earth metal salts (eg, calcium salt, magnesium salt, etc.), ammonium salts, organic amine salts (eg, monoethanolamine salt, etc.). , Diethanolamine salt, triethanolamine salt, etc.) and the like are exemplified. In the present invention, vitamin A (retinol) is particularly preferably used from the viewpoint of stability, effectiveness and the like. As the vitamin A and / or its derivative, one kind or two or more kinds can be used.
本発明の組成物におけるビタミンA及び/又はその誘導体の配合量は、組成物全量に対して少なくとも0.01質量%であり、好ましくは0.05質量%である。0.01質量%未満の配合量では、しわ改善効果を十分に発揮することが困難である。一方、本発明の組成物には、ビタミンA及び/又はその誘導体を比較的多量に安定配合できるので、その配合量の上限は特に限られない。例えば、10質量%以下、5質量%以下、あるいは4質量%以下等の上限値を設定可能である。即ち、本発明の組成物では、限定されないが、例えば、0.01~4質量%、又は0.05~5質量%といったビタミンA及び/又はその誘導体の配合量範囲を選択できる。
The blending amount of vitamin A and / or its derivative in the composition of the present invention is at least 0.01% by mass, preferably 0.05% by mass, based on the total amount of the composition. If the blending amount is less than 0.01% by mass, it is difficult to sufficiently exert the wrinkle improving effect. On the other hand, since a relatively large amount of vitamin A and / or a derivative thereof can be stably blended in the composition of the present invention, the upper limit of the blending amount is not particularly limited. For example, an upper limit value such as 10% by mass or less, 5% by mass or less, or 4% by mass or less can be set. That is, in the composition of the present invention, for example, a blending amount range of vitamin A and / or a derivative thereof such as 0.01 to 4% by mass or 0.05 to 5% by mass can be selected without limitation.
第2の油相に配合する油分(「第2の油分」ともいう)は、極性油を必須成分として含有し、化粧料や皮膚外用剤に配合可能な他の油分を含有していてもよい。極性油は、エステル油及び紫外線吸収剤から選択するのが好ましい。他の油分としては、例えば、天然油脂、ロウ類等が挙げられる。
The oil component to be blended in the second oil phase (also referred to as "second oil component") may contain polar oil as an essential component and may contain other oil components that can be blended in cosmetics and external preparations for skin. .. The polar oil is preferably selected from ester oils and UV absorbers. Examples of other oils include natural fats and oils, waxes and the like.
エステル油の具体例としては、ミリスチン酸イソプロピル、オクタン酸セチル、ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、ステアリン酸ブチル、ラウリン酸ヘキシル、ミリスチン酸ミリスチル、オレイン酸デシル、ジメチルオクタン酸ヘキシルデシル、乳酸セチル、乳酸ミリスチル、酢酸ラノリン、ステアリン酸イソセチル、イソステアリン酸イソセチル、12-ヒドロキシステアリン酸コレステリル、ジ-2-エチルヘキサン酸エチレングリコール、ジペンタエリスリトール脂肪酸エステル、モノイソステアリン酸N-アルキルグリコール、ジカプリン酸ネオペンチルグリコール、リンゴ酸ジイソステアリル、ジ-2-ヘプチルウンデカン酸グリセリン、トリ-2-エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ-2-エチルヘキサン酸ペンタエリスリット、トリ-2-エチルヘキサン酸グリセリン、トリオクタン酸グリセリン、トリイソパルミチン酸グリセリン、セチル2-エチルヘキサノエート、2-エチルヘキシルパルミテート、トリミリスチン酸グリセリン、トリ-2-ヘプチルウンデカン酸グリセライド、ヒマシ油脂肪酸メチルエステル、オレイン酸オレイル、アセトグリセライド、パルミチン酸2-ヘプチルウンデシル、アジピン酸ジイソブチル、N-ラウロイル-L-グルタミン酸-2-オクチルドデシルエステル、アジピン酸ジ-2-ヘプチルウンデシル、エチルラウレート、セバシン酸ジ2-エチルヘキシル、ミリスチン酸2-ヘキシルデシル、パルミチン酸2-ヘキシルデシル、アジピン酸2-ヘキシルデシル、セバシン酸ジイソプロピル、コハク酸2-エチルヘキシル、クエン酸トリエチル等が挙げられる。
Specific examples of the ester oil include isopropyl myristate, cetyl octanoate, octyldodecyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, myristyl myristate, decyl oleate, hexyl decyl dimethyl octanate, and cetyl lactate. Myristyl Lactate, Lanolin Acetate, Isocetyl Stearate, Isocetyl Isostearate, Cholesteryl 12-Hydroxystearate, Ethylene Glycol Di-2-ethylhexanoate, Dipentaerythritol Fatty Acid Ester, N-alkyl Glycol Monoisostearate, Neopentyl Glycol Dicaprate , Diisostearyl malate, Glycerin di-2-heptylundecanoate, Trimethylolpropane tri-2-ethylhexanoate, Trimethylolpropane triisostearate, Pentaerislit tetra-2-ethylhexanoate, Tri-2-ethyl Glycerin hexanoate, glycerin trioctanoate, glycerin triisopalmitate, cetyl 2-ethylhexanoate, 2-ethylhexyl palmitate, glycerin trimyristate, glyceride tri-2-heptylundecanoate, methyl ester of castor oil fatty acid, oleic acid Oleyl, acetoglyceride, 2-heptyl undecyl palmitate, diisobutyl adipate, N-lauroyl-L-glutamic acid-2-octyldodecyl ester, di-2-heptyl undecyl adipylate, ethyllaurate, di2-sebacate Examples thereof include ethylhexyl, 2-hexyldecyl myristate, 2-hexyldecyl palmitate, 2-hexyldecyl adipate, diisopropyl sebacate, 2-ethylhexyl succinate, and triethyl citrate.
第2の油分に含まれる極性油として、上記のエステル油に代えて又はエステル油に加えて、油溶性の紫外線吸収剤を配合することができる。油溶性の紫外線吸収剤としては、通常化粧料や皮膚外用剤に使用可能なものを用いることができ、例えば、トリアジン系紫外線吸収剤、安息香酸系紫外線吸収剤、アントラニル酸系紫外線吸収剤、サリチル酸系紫外線吸収剤、ケイ皮酸系紫外線吸収剤、ベンゾフェノン系紫外線吸収剤等が挙げられる。中でも、常温で液状の紫外線吸収剤であるパラメトキシケイ皮酸2-エチルヘキシル等が好ましく用いられる。
As the polar oil contained in the second oil component, an oil-soluble ultraviolet absorber can be blended in place of the above ester oil or in addition to the ester oil. As the oil-soluble UV absorber, those that can be usually used for cosmetics and external skin preparations can be used. For example, triazine-based UV absorbers, benzoic acid-based UV absorbers, anthranilic acid-based UV absorbers, and salicylic acid. Examples thereof include UV absorbers, silicic acid UV absorbers, and benzophenone UV absorbers. Of these, 2-ethylhexyl paramethoxycinnamate, which is an ultraviolet absorber that is liquid at room temperature, is preferably used.
第2の油相における油分(第2の油分)の配合量は、組成物全量に対して5~40質量%である。第2の油分は極性油を含むのが好ましい。当該極性油の配合量は、組成物全量に対して、好ましくは1~35質量%、より好ましくは10~30質量%である。当該極性油が第2の油相全量に対して占める割合(質量%)は、15質量%以上とするのが好ましく、より好ましくは30質量%以上、更に好ましくは45質量%以上である。
また、極性油はエステル油を含むのが好ましく、当該エステル油が極性油の全量に対して占める割合(質量%)を、50質量%以上とするのが好ましく、より好ましくは60質量%以上である。 The blending amount of the oil component (second oil component) in the second oil phase is 5 to 40% by mass with respect to the total amount of the composition. The second oil preferably contains polar oil. The blending amount of the polar oil is preferably 1 to 35% by mass, more preferably 10 to 30% by mass, based on the total amount of the composition. The ratio (mass%) of the polar oil to the total amount of the second oil phase is preferably 15% by mass or more, more preferably 30% by mass or more, and further preferably 45% by mass or more.
Further, the polar oil preferably contains an ester oil, and the ratio (mass%) of the ester oil to the total amount of the polar oil is preferably 50% by mass or more, more preferably 60% by mass or more. be.
また、極性油はエステル油を含むのが好ましく、当該エステル油が極性油の全量に対して占める割合(質量%)を、50質量%以上とするのが好ましく、より好ましくは60質量%以上である。 The blending amount of the oil component (second oil component) in the second oil phase is 5 to 40% by mass with respect to the total amount of the composition. The second oil preferably contains polar oil. The blending amount of the polar oil is preferably 1 to 35% by mass, more preferably 10 to 30% by mass, based on the total amount of the composition. The ratio (mass%) of the polar oil to the total amount of the second oil phase is preferably 15% by mass or more, more preferably 30% by mass or more, and further preferably 45% by mass or more.
Further, the polar oil preferably contains an ester oil, and the ratio (mass%) of the ester oil to the total amount of the polar oil is preferably 50% by mass or more, more preferably 60% by mass or more. be.
第2の油相は、高級アルコール及び/又は高級脂肪酸(以下「高級アルコール等」ともいう)、並びに界面活性剤(「第2の界面活性剤」という)を含むのが好ましい。
The second oil phase preferably contains a higher alcohol and / or a higher fatty acid (hereinafter also referred to as "higher alcohol or the like") and a surfactant (referred to as "second surfactant").
第2の油相に配合する高級アルコール等としては、例えば、ドデカノール(ラウリルアルコール)、トリドデカノール、テトラドデカノール(ミリスチルアルコール)、ペンタデカノール、ヘキサデカノール(セチルアルコール)、ヘプタデカノール、オクタデカノール(ステアリルアルコール)、ノナデカノール、イコサノール(アラキルアルコール)、ヘンイコサノール、ドコサノール(ベヘニルアルコール)、トリコサノール、テトラコサノール(カルナービルアルコール)、ペンタコサノール、ヘキサコサノール(セリルアルコール)、バチルアルコール、エライジルアルコール等が挙げられる。
Examples of the higher alcohol to be blended in the second oil phase include dodecanol (lauryl alcohol), tridodecanol, tetradodecanol (myristyl alcohol), pentadecanol, hexadecanol (cetyl alcohol), heptadecanol, and the like. Octadecanol (stearyl alcohol), nonadecanol, icosanol (araquil alcohol), henicosanol, docosanol (behenyl alcohol), tricosanol, tetracosanol (carnavir alcohol), pentacosanol, hexacosanol (ceryl alcohol), bacil alcohol, Elysyl alcohol and the like can be mentioned.
高級アルコール等は、上記の1種または2種以上を用いることができる。本発明では2種以上の脂肪族アルコールの混合物を用いるのが好ましく、さらに好ましくは、その混合物の融点が60℃以上となるような組み合わせである。この融点は60℃未満であると、処方によっては系の温度安定性が低下する場合がある。本発明では、例えば、ステアリルアルコール、ベヘニルアルコール及びバチルアルコールの組み合わせが特に好ましい。
As the higher alcohol, etc., one or more of the above can be used. In the present invention, it is preferable to use a mixture of two or more kinds of aliphatic alcohols, and more preferably, the combination is such that the melting point of the mixture is 60 ° C. or higher. If this melting point is less than 60 ° C., the temperature stability of the system may decrease depending on the formulation. In the present invention, for example, a combination of stearyl alcohol, behenyl alcohol and batyl alcohol is particularly preferable.
本発明の化粧料組成物における高級アルコール等の配合量は、特に限定されないが、0.3~10質量%、好ましくは0.5~9質量%である。
The blending amount of the higher alcohol or the like in the cosmetic composition of the present invention is not particularly limited, but is 0.3 to 10% by mass, preferably 0.5 to 9% by mass.
第2の油相に配合する第2の界面活性剤としては、非イオン性界面活性剤が好ましい。例えば、直鎖飽和アルキル(好ましくは炭素数12~22)とポリアルキレングリコール(ポリエチレンオキシド、ポリプロピレンオキシド、ポリブチレンオキシド等)とのエーテルを用いるのが好ましい。具体例としては、グリセリンモノステアリルエーテル、POE(20)セチルエーテル、POE(30)セチルエーテル、POE(20)ステアリルエーテル、POE(25)ステアリルエーテル、POE(30)ステアリルエーテル、POE(20)ベヘニルエーテル、POE(30)ベヘニルエーテル、POE(60)モノイソステアリン酸グリセリン、POE(20)モノステアリン酸ソルビタン、ヤシ油脂肪酸ソルビタン、ヤシ油脂肪酸PEG-7グリセリル、ラウラミドMEA、ラウリルピリジニウムクロリド、ラウリン酸PEG-32、ラウリン酸PEG-40硬化ヒマシ油、オレイン酸PEG-14、オレイン酸ポリグリセリル-6、ジラウリン酸PEG-32、PEG-11コカミド等を挙げることができるが、これらに限定されない。特に、POE(20)セチルエーテル、POE(30)セチルエーテル、POE(20)ステアリルエーテル、POE(30)ステアリルエーテル、POE(30)ベヘニルエーテル等が挙げられる。「POE」とはポリオキシエチレンの略である。
As the second surfactant to be blended in the second oil phase, a nonionic surfactant is preferable. For example, it is preferable to use an ether of linear saturated alkyl (preferably 12 to 22 carbon atoms) and polyalkylene glycol (polyethylene oxide, polypropylene oxide, polybutylene oxide, etc.). Specific examples include glycerin monostearyl ether, POE (20) cetyl ether, POE (30) cetyl ether, POE (20) stearyl ether, POE (25) stearyl ether, POE (30) stearyl ether, POE (20) behenyl. Ether, POE (30) behenyl ether, POE (60) glycerin monoisostearate, POE (20) sorbitan monostearate, sorbitan coconut oil fatty acid, PEG-7 glyceryl coconut oil fatty acid, lauramide MEA, laurylpyridinium chloride, PEG laurate -32, PEG-40 cured castor oil laurate, PEG-14 oleate, polyglyceryl-6 oleate, PEG-32 dilaurate, PEG-11 cocamide and the like can be mentioned, but are not limited thereto. In particular, POE (20) cetyl ether, POE (30) cetyl ether, POE (20) stearyl ether, POE (30) stearyl ether, POE (30) behenyl ether and the like can be mentioned. "POE" is an abbreviation for polyoxyethylene.
第2の界面活性剤の配合量は、組成物全量に対して0.3~10質量%が好ましく、0.5~5質量%の範囲内とするのが更に好ましい。
The blending amount of the second surfactant is preferably 0.3 to 10% by mass, more preferably 0.5 to 5% by mass, based on the total amount of the composition.
第2の油相に高級アルコール等と第2の界面活性剤を配合することにより、水の存在下において高級アルコール等が第2の界面活性剤とともにラメラ状の2分子膜からなる会合体を形成し、いわゆるα-ゲル構造をとることができ、系の安定化に寄与する。
By blending a higher alcohol or the like and a second surfactant in the second oil phase, the higher alcohol or the like forms an aggregate composed of a lamellar bilayer film together with the second surfactant in the presence of water. However, it can take a so-called α-gel structure and contributes to the stabilization of the system.
本発明の組成物は、粉末を第1の油相に配合し、紫外線吸収剤などの極性油を第2の油相に配合することにより安定化されているため、特許文献1に記載されているような3種の特定の界面活性剤の組み合わせを用いる必要はない。従って、本発明の組成物は、トリステアリン酸ソルビタン、ポリエチレングリコールの付加モル数が20~120であるステアリン酸ポリエチレングリコール、及びHLBが5~8のステアリン酸グリセリルのいずれか1種以上を含まない態様を包含する。
The composition of the present invention is described in Patent Document 1 because it is stabilized by blending powder in the first oil phase and blending a polar oil such as an ultraviolet absorber in the second oil phase. It is not necessary to use a combination of three specific surfactants as described above. Therefore, the composition of the present invention does not contain any one or more of sorbitan tristearate, polyethylene glycol stearate having an addition molar number of 20 to 120, and glyceryl stearate having an HLB of 5 to 8. Includes aspects.
<水相>
本発明の組成物は、上記した第1の油相及び第2の油相を水相中に分散した水中油型乳化組成物である。
本発明の乳化組成物における連続相である水相は水を含み、任意に水性成分を含有している。水性成分とは、水に可溶性または相溶性の成分である。 <Aquatic phase>
The composition of the present invention is an oil-in-water emulsified composition in which the above-mentioned first oil phase and second oil phase are dispersed in an aqueous phase.
The aqueous phase, which is a continuous phase in the emulsified composition of the present invention, contains water and optionally contains an aqueous component. Aqueous components are components that are soluble or compatible with water.
本発明の組成物は、上記した第1の油相及び第2の油相を水相中に分散した水中油型乳化組成物である。
本発明の乳化組成物における連続相である水相は水を含み、任意に水性成分を含有している。水性成分とは、水に可溶性または相溶性の成分である。 <Aquatic phase>
The composition of the present invention is an oil-in-water emulsified composition in which the above-mentioned first oil phase and second oil phase are dispersed in an aqueous phase.
The aqueous phase, which is a continuous phase in the emulsified composition of the present invention, contains water and optionally contains an aqueous component. Aqueous components are components that are soluble or compatible with water.
水相に界面活性剤(「第3の界面活性剤」という)を配合することにより、乳化系の安定性が更に向上する。
第3の界面活性剤としては、比較的嵩高い分子構造を有する非イオン性の親水性界面活性剤を選択するのが好ましい。具体的には、例えば、ポリオキシエチレン硬化ヒマシ油(10E.O.)、ポリオキシエチレン硬化ヒマシ油(20E.O.)、ポリオキシエチレン硬化ヒマシ油(30E.O.)、ポリオキシエチレン硬化ヒマシ油(40E.O.)、ポリオキシエチレン硬化ヒマシ油(50E.O.)、ポリオキシエチレン硬化ヒマシ油(60E.O.)、ポリオキシエチレン硬化ヒマシ油(100E.O.)等のポリオキシエチレン硬化ヒマシ油、ステアリン酸ポリオキシエチレングリセリル、イソステアリン酸ポリオキシエチレングリセリル、トリイソステアリン酸ポリオキシエチレングリセリル、ポリオキシエチレン硬化ヒマシ油コハク酸からなる群から選択される少なくとも1種の非イオン性界面活性剤が好ましく用いられる。 By blending a surfactant (referred to as "third surfactant") in the aqueous phase, the stability of the emulsification system is further improved.
As the third surfactant, it is preferable to select a nonionic hydrophilic surfactant having a relatively bulky molecular structure. Specifically, for example, polyoxyethylene hydrogenated castor oil (10EO), polyoxyethylene hydrogenated castor oil (20EO), polyoxyethylene hydrogenated castor oil (30EO), polyoxyethylene hydrogenated Poly such as castor oil (40EO), polyoxyethylene hydrogenated castor oil (50EO), polyoxyethylene hydrogenated castor oil (60EO), polyoxyethylene hydrogenated castor oil (100EO), etc. At least one nonionic selected from the group consisting of oxyethylene hydrogenated castor oil, polyoxyethylene glyceryl stearate, polyoxyethylene glyceryl isostearate, polyoxyethylene glyceryl triisostearate, and polyoxyethylene hydrogenated castor oil succinic acid. A surfactant is preferably used.
第3の界面活性剤としては、比較的嵩高い分子構造を有する非イオン性の親水性界面活性剤を選択するのが好ましい。具体的には、例えば、ポリオキシエチレン硬化ヒマシ油(10E.O.)、ポリオキシエチレン硬化ヒマシ油(20E.O.)、ポリオキシエチレン硬化ヒマシ油(30E.O.)、ポリオキシエチレン硬化ヒマシ油(40E.O.)、ポリオキシエチレン硬化ヒマシ油(50E.O.)、ポリオキシエチレン硬化ヒマシ油(60E.O.)、ポリオキシエチレン硬化ヒマシ油(100E.O.)等のポリオキシエチレン硬化ヒマシ油、ステアリン酸ポリオキシエチレングリセリル、イソステアリン酸ポリオキシエチレングリセリル、トリイソステアリン酸ポリオキシエチレングリセリル、ポリオキシエチレン硬化ヒマシ油コハク酸からなる群から選択される少なくとも1種の非イオン性界面活性剤が好ましく用いられる。 By blending a surfactant (referred to as "third surfactant") in the aqueous phase, the stability of the emulsification system is further improved.
As the third surfactant, it is preferable to select a nonionic hydrophilic surfactant having a relatively bulky molecular structure. Specifically, for example, polyoxyethylene hydrogenated castor oil (10EO), polyoxyethylene hydrogenated castor oil (20EO), polyoxyethylene hydrogenated castor oil (30EO), polyoxyethylene hydrogenated Poly such as castor oil (40EO), polyoxyethylene hydrogenated castor oil (50EO), polyoxyethylene hydrogenated castor oil (60EO), polyoxyethylene hydrogenated castor oil (100EO), etc. At least one nonionic selected from the group consisting of oxyethylene hydrogenated castor oil, polyoxyethylene glyceryl stearate, polyoxyethylene glyceryl isostearate, polyoxyethylene glyceryl triisostearate, and polyoxyethylene hydrogenated castor oil succinic acid. A surfactant is preferably used.
本発明の組成物における第3の界面活性剤の配合量は、組成物全量に対して0.3~10質量%とするのが好ましく、0.5~9質量%の範囲内とするのが更に好ましい。
The blending amount of the third surfactant in the composition of the present invention is preferably 0.3 to 10% by mass, preferably in the range of 0.5 to 9% by mass, based on the total amount of the composition. More preferred.
また、水相に増粘剤を配合すると、経時による乳化油滴の沈降やクリーミング、さらには粉体の凝集を抑制して、乳化安定性が更に改善できるので好ましい。
Further, it is preferable to add a thickener to the aqueous phase because the emulsification stability can be further improved by suppressing the sedimentation and creaming of the emulsified oil droplets and the aggregation of the powder over time.
水相に配合する増粘剤は、化粧料や医薬部外品に使用できる水相増粘剤であれば特に限定されない。例えば、キサンタンガム、セルロース(カルボキシメチルセルロース(塩)等)、アラビアガム、カラギーナン、ペクチン、カンテン、クインスシード(マルメロ)エキス、デンプン、アルゲコロイド(褐藻エキス)、ムコ多糖類、シロキクラゲ多糖体、サクシノグリカン等の植物系高分子、デキストラン、プルラン等の微生物系高分子、コラーゲン、カゼイン、ゼラチン等の動物系高分子、カルボキシメチルデンプン、メチルヒドロキシプロピルデンプン等のデンプン系高分子、(アクリル酸Na・アクリロイルジメチルタウリンNa)コポリマー、(ジメチルアクリルアミド/アクリロイルジメチルタウリンNa)クロスポリマー、2-アクリルアミド-2-メチルプロパンスルホン酸を含む共重合体等のアクリル酸系ポリマー等を挙げることができる。
増粘剤の配合量としては、組成物全量に対して0.1~6質量%が好ましい。 The thickener to be blended in the aqueous phase is not particularly limited as long as it is an aqueous phase thickener that can be used in cosmetics and quasi-drugs. For example, xanthan gum, cellulose (carboxymethyl cellulose (salt), etc.), Arabic gum, carrageenan, pectin, canten, quince seed (malmero) extract, starch, algae colloid (brown algae extract), mucopolysaccharide, white jellyfish polysaccharide, succinoglycan. Plant-based polymers such as dextran and purulan, animal-based polymers such as collagen, casein and gelatin, starch-based polymers such as carboxymethyl starch and methylhydroxypropyl starch, (Na acrylate, acryloyl). Examples thereof include acrylic acid-based polymers such as dimethyl taurine Na) copolymers, (dimethyl acrylamide / acryloyl dimethyl taurine Na) cross polymers, and copolymers containing 2-acrylamide-2-methylpropansulfonic acid.
The amount of the thickener to be blended is preferably 0.1 to 6% by mass with respect to the total amount of the composition.
増粘剤の配合量としては、組成物全量に対して0.1~6質量%が好ましい。 The thickener to be blended in the aqueous phase is not particularly limited as long as it is an aqueous phase thickener that can be used in cosmetics and quasi-drugs. For example, xanthan gum, cellulose (carboxymethyl cellulose (salt), etc.), Arabic gum, carrageenan, pectin, canten, quince seed (malmero) extract, starch, algae colloid (brown algae extract), mucopolysaccharide, white jellyfish polysaccharide, succinoglycan. Plant-based polymers such as dextran and purulan, animal-based polymers such as collagen, casein and gelatin, starch-based polymers such as carboxymethyl starch and methylhydroxypropyl starch, (Na acrylate, acryloyl). Examples thereof include acrylic acid-based polymers such as dimethyl taurine Na) copolymers, (dimethyl acrylamide / acryloyl dimethyl taurine Na) cross polymers, and copolymers containing 2-acrylamide-2-methylpropansulfonic acid.
The amount of the thickener to be blended is preferably 0.1 to 6% by mass with respect to the total amount of the composition.
本発明の組成物に、シリコーンエラストマー粉末を配合すると、べたつきを抑制し、組成物の使用性を更に改善することができる。特に、シリコーンエラストマーの球状粉末、中でも、球状シリコーンゴム粉末をシリコーン樹脂で被覆した白色球状のシリコーン複合粉末を配合するのが好ましい。シリコーンエラストマー球状粉末は、平均粒径が好ましくは0.1~100μm、より好ましくは1~50μmであり、JIS-A硬度が10~80の範囲とするのが好ましい。シリコーンエラストマー粉末の具体例としては、化粧品成分表示名称でいうところの、(ビニルジメチコン/メチコンシルセスキオキサン)クロスポリマー、(ジフェニルジメチコン/ビニルジフェニルジメチコン/シルセスキオキサン)クロスポリマー、ポリシリコーン-1クロスポリマー、ポリシリコーン-22、(ジメチコン/ビニルジメチコン/メチコン)クロスポリマー等から選択される1種又は2種以上が好適に用いられる。シリコーンエラストマー粉末の配合量は1~10質量%とするのが好ましく、2~8質量%がより好ましい。
シリコーンエラストマー粉末は、油相又は水相のいずれに配合してもよいが、水相に配合することが好ましい。 When the silicone elastomer powder is blended with the composition of the present invention, stickiness can be suppressed and the usability of the composition can be further improved. In particular, it is preferable to blend a spherical powder of a silicone elastomer, particularly a white spherical silicone composite powder in which a spherical silicone rubber powder is coated with a silicone resin. The average particle size of the silicone elastomer spherical powder is preferably 0.1 to 100 μm, more preferably 1 to 50 μm, and the JIS-A hardness is preferably in the range of 10 to 80. Specific examples of the silicone elastomer powder include (vinyldimethicone / methicone silsesquioxane) crosspolymer, (diphenyldimethicone / vinyldiphenyldimethicone / silsesquioxane) crosspolymer, and polysilicone-in the cosmetic ingredient labeling name. One or more selected from 1 cross polymer, polysilicone-22, (dimethicone / vinyldimethicone / methicone) cross polymer and the like are preferably used. The blending amount of the silicone elastomer powder is preferably 1 to 10% by mass, more preferably 2 to 8% by mass.
The silicone elastomer powder may be blended in either the oil phase or the aqueous phase, but is preferably blended in the aqueous phase.
シリコーンエラストマー粉末は、油相又は水相のいずれに配合してもよいが、水相に配合することが好ましい。 When the silicone elastomer powder is blended with the composition of the present invention, stickiness can be suppressed and the usability of the composition can be further improved. In particular, it is preferable to blend a spherical powder of a silicone elastomer, particularly a white spherical silicone composite powder in which a spherical silicone rubber powder is coated with a silicone resin. The average particle size of the silicone elastomer spherical powder is preferably 0.1 to 100 μm, more preferably 1 to 50 μm, and the JIS-A hardness is preferably in the range of 10 to 80. Specific examples of the silicone elastomer powder include (vinyldimethicone / methicone silsesquioxane) crosspolymer, (diphenyldimethicone / vinyldiphenyldimethicone / silsesquioxane) crosspolymer, and polysilicone-in the cosmetic ingredient labeling name. One or more selected from 1 cross polymer, polysilicone-22, (dimethicone / vinyldimethicone / methicone) cross polymer and the like are preferably used. The blending amount of the silicone elastomer powder is preferably 1 to 10% by mass, more preferably 2 to 8% by mass.
The silicone elastomer powder may be blended in either the oil phase or the aqueous phase, but is preferably blended in the aqueous phase.
本発明の組成物は、本発明の効果を損なわない範囲で、化粧料や医薬部外品に汎用されている各種成分を添加することができる。例えば、ビタミンB群、ビタミンC及びその誘導体、4-メトキシサリチル酸カリウム、トラネキサム酸、パントテン酸及びその誘導体、ビオチン等のビタミン類などの水溶性活性物質または安定化剤、保湿剤、ビタミンE、アルギニン、アスパラギン酸、クエン酸、酒石酸、乳酸などの緩衝剤、EDTAなどのキレート剤、防腐剤、色材等が挙げられる。
The composition of the present invention can be added with various ingredients widely used in cosmetics and quasi-drugs as long as the effects of the present invention are not impaired. For example, water-soluble active substances or stabilizers such as vitamin B group, vitamin C and its derivatives, potassium 4-methoxysalicylate, tranexamic acid, pantothenic acid and its derivatives, vitamins such as biotin, moisturizers, vitamin E, arginine. , Aspartic acid, citric acid, tartaric acid, buffers such as lactic acid, chelating agents such as EDTA, preservatives, coloring materials and the like.
本発明の組成物の製造方法は、特に制限されないが、例えば、第1の油相成分を水相の一部に分散させた水中油型乳化物(「第1の乳化物」という)を調製し、第2の油相成分を残りの水相に分散させた水中油型乳化物(「第2の乳化物」という)を別途調製し、その後に第1の乳化物と第2の乳化物とを混合することにより製造できる。
あるいは、第1の油相成分を水相に分散させた第1の乳化物を調製した後、当該第1の乳化物に第2の油相成分を添加して乳化することによっても製造できる。 The method for producing the composition of the present invention is not particularly limited, but for example, an oil-in-water emulsion (referred to as "first emulsion") in which the first oil phase component is dispersed in a part of the aqueous phase is prepared. Then, an oil-in-water emulsion (referred to as "second emulsion") in which the second oil phase component is dispersed in the remaining aqueous phase is separately prepared, and then the first emulsion and the second emulsion are prepared. Can be manufactured by mixing with.
Alternatively, it can also be produced by preparing a first emulsion in which the first oil phase component is dispersed in an aqueous phase, and then adding a second oil phase component to the first emulsion and emulsifying it.
あるいは、第1の油相成分を水相に分散させた第1の乳化物を調製した後、当該第1の乳化物に第2の油相成分を添加して乳化することによっても製造できる。 The method for producing the composition of the present invention is not particularly limited, but for example, an oil-in-water emulsion (referred to as "first emulsion") in which the first oil phase component is dispersed in a part of the aqueous phase is prepared. Then, an oil-in-water emulsion (referred to as "second emulsion") in which the second oil phase component is dispersed in the remaining aqueous phase is separately prepared, and then the first emulsion and the second emulsion are prepared. Can be manufactured by mixing with.
Alternatively, it can also be produced by preparing a first emulsion in which the first oil phase component is dispersed in an aqueous phase, and then adding a second oil phase component to the first emulsion and emulsifying it.
本発明の組成物は、水中油型乳化物に特有のみずみずしい感触を持ちながら、塗布直後に即座に得られる肌補正効果を発揮するのみならず、配合されたビタミンA類によるしわ改善効果を長期に亘り発揮する。
The composition of the present invention not only exerts a skin-correcting effect immediately after application while having a fresh feel peculiar to an oil-in-water emulsion, but also has a long-term wrinkle improving effect due to the blended vitamin As. Demonstrate over.
よって、水性基礎化粧料、ファンデーション又は化粧下地等のメーキャップ化粧料、あるいは乳液や美容液等のスキンケア化粧料として使用するのに特に適したものである。
本発明は、上述した本発明の組成物からなる水中油型乳化化粧料、特に皮膚化粧料を提供する。本発明の水中油型乳化化粧料の形態は特に限定されず、クリーム、乳液、またはジェル等の様々な形態で提供することができる。 Therefore, it is particularly suitable for use as a water-based basic cosmetic, a makeup cosmetic such as a foundation or a makeup base, or a skin care cosmetic such as a milky lotion or a beauty essence.
The present invention provides an oil-in-water emulsified cosmetic, particularly a skin cosmetic, comprising the composition of the present invention described above. The form of the oil-in-water emulsified cosmetic of the present invention is not particularly limited, and can be provided in various forms such as cream, milky lotion, or gel.
本発明は、上述した本発明の組成物からなる水中油型乳化化粧料、特に皮膚化粧料を提供する。本発明の水中油型乳化化粧料の形態は特に限定されず、クリーム、乳液、またはジェル等の様々な形態で提供することができる。 Therefore, it is particularly suitable for use as a water-based basic cosmetic, a makeup cosmetic such as a foundation or a makeup base, or a skin care cosmetic such as a milky lotion or a beauty essence.
The present invention provides an oil-in-water emulsified cosmetic, particularly a skin cosmetic, comprising the composition of the present invention described above. The form of the oil-in-water emulsified cosmetic of the present invention is not particularly limited, and can be provided in various forms such as cream, milky lotion, or gel.
以下に実施例を挙げて本発明を更に詳述するが、本発明は実施例により限定されるものではない。なお、配合量は特記しない限り質量%で示す。
The present invention will be described in more detail with reference to Examples below, but the present invention is not limited to the Examples. Unless otherwise specified, the blending amount is shown in% by mass.
下記の表1及び表2に掲げた処方で水中油型乳化組成物を調製した。
各実施例の組成物は以下の要領で製造した。
(1)水相を調製する。
(2)分散処理を施した第1の油相(油相1)を調製する。
(3)第1の油相を水相と混合して第1の乳化物を調製する。
(4)第2の油相成分(油相2)を加熱混合して第2の油相を調製する。
(5)第2の油相を第1の乳化物と混合し、室温まで冷却させる。 An oil-in-water emulsified composition was prepared according to the formulations listed in Tables 1 and 2 below.
The composition of each example was produced as follows.
(1) Prepare an aqueous phase.
(2) A first oil phase (oil phase 1) that has been subjected to a dispersion treatment is prepared.
(3) The first oil phase is mixed with the aqueous phase to prepare a first emulsion.
(4) The second oil phase component (oil phase 2) is heated and mixed to prepare a second oil phase.
(5) The second oil phase is mixed with the first emulsion and cooled to room temperature.
各実施例の組成物は以下の要領で製造した。
(1)水相を調製する。
(2)分散処理を施した第1の油相(油相1)を調製する。
(3)第1の油相を水相と混合して第1の乳化物を調製する。
(4)第2の油相成分(油相2)を加熱混合して第2の油相を調製する。
(5)第2の油相を第1の乳化物と混合し、室温まで冷却させる。 An oil-in-water emulsified composition was prepared according to the formulations listed in Tables 1 and 2 below.
The composition of each example was produced as follows.
(1) Prepare an aqueous phase.
(2) A first oil phase (oil phase 1) that has been subjected to a dispersion treatment is prepared.
(3) The first oil phase is mixed with the aqueous phase to prepare a first emulsion.
(4) The second oil phase component (oil phase 2) is heated and mixed to prepare a second oil phase.
(5) The second oil phase is mixed with the first emulsion and cooled to room temperature.
前記表1及び表2に記載した各例の組成物について下記の評価を実施した。評価結果を併記する。
The following evaluations were carried out for the compositions of each example shown in Tables 1 and 2 above. The evaluation results are also shown.
<乳化安定性(経時安定性)>
各例の組成物を、50℃で1ヶ月保存し、外観を目視観察することにより、下記の基準で乳化安定性を評価した。
A:1ヶ月(50℃)経過後に、外観に変化(分離)がみられなかった。
B:1ヶ月(50℃)経過後に、やや分離がみられた。
C:1ヶ月(50℃)経過後に、明らかな分離がみられた。 <Emulsification stability (stability over time)>
The compositions of each example were stored at 50 ° C. for 1 month, and the appearance was visually observed to evaluate the emulsion stability according to the following criteria.
A: No change (separation) was observed in the appearance after 1 month (50 ° C.).
B: Slight separation was observed after 1 month (50 ° C).
C: After 1 month (50 ° C), a clear separation was observed.
各例の組成物を、50℃で1ヶ月保存し、外観を目視観察することにより、下記の基準で乳化安定性を評価した。
A:1ヶ月(50℃)経過後に、外観に変化(分離)がみられなかった。
B:1ヶ月(50℃)経過後に、やや分離がみられた。
C:1ヶ月(50℃)経過後に、明らかな分離がみられた。 <Emulsification stability (stability over time)>
The compositions of each example were stored at 50 ° C. for 1 month, and the appearance was visually observed to evaluate the emulsion stability according to the following criteria.
A: No change (separation) was observed in the appearance after 1 month (50 ° C.).
B: Slight separation was observed after 1 month (50 ° C).
C: After 1 month (50 ° C), a clear separation was observed.
<肌補正効果>
各例の組成物(製造直後)を専門パネル(10名)が顔面に塗布し、塗布後の肌の補正効果について下記の基準で効果実感を評価した。
A:9名以上が「効果実感がある」と評価した。
B:6~8名が「効果実感がある」と評価した。
C:4~5名が「効果実感がある」と評価した。
D:3名以下が「効果実感がある」と評価した。 <Skin correction effect>
The composition of each example (immediately after production) was applied to the face by a specialized panel (10 people), and the actual feeling of the effect was evaluated for the skin correction effect after application according to the following criteria.
A: Nine or more people evaluated that they had a "real feeling of effect."
B: 6 to 8 people evaluated that they "have a real feeling of effect."
C: 4 to 5 people evaluated that "there is a real feeling of effect".
D: 3 or less evaluated that "there is a real feeling of effect".
各例の組成物(製造直後)を専門パネル(10名)が顔面に塗布し、塗布後の肌の補正効果について下記の基準で効果実感を評価した。
A:9名以上が「効果実感がある」と評価した。
B:6~8名が「効果実感がある」と評価した。
C:4~5名が「効果実感がある」と評価した。
D:3名以下が「効果実感がある」と評価した。 <Skin correction effect>
The composition of each example (immediately after production) was applied to the face by a specialized panel (10 people), and the actual feeling of the effect was evaluated for the skin correction effect after application according to the following criteria.
A: Nine or more people evaluated that they had a "real feeling of effect."
B: 6 to 8 people evaluated that they "have a real feeling of effect."
C: 4 to 5 people evaluated that "there is a real feeling of effect".
D: 3 or less evaluated that "there is a real feeling of effect".
<しわ改善効果>
各例の組成物を、アルミホイルで遮光して、50℃で1ヶ月保存した。1ヶ月(50℃)経過後の組成物中のビタミンA量を、高速液体クロマトグラフィーで分析し、製造直後のビタミンA量に対する残存率(%)を算出した。残存率が高いほどビタミンAの活性が維持され、しわ改善効果を発揮する。
使用した高速液体クロマトグラフィーの条件は以下の通りである。
カラム:C18カラム(株式会社資生堂製)
検出:UV310nm
移動相:72%エタノール/10%アセトニトリル/17.5%イオン交換水/0.5%酢酸 <Wrinkle improvement effect>
The compositions of each example were shielded from light with aluminum foil and stored at 50 ° C. for 1 month. The amount of vitamin A in the composition after 1 month (50 ° C.) was analyzed by high performance liquid chromatography, and the residual ratio (%) with respect to the amount of vitamin A immediately after production was calculated. The higher the residual rate, the more the activity of vitamin A is maintained and the effect of improving wrinkles is exhibited.
The conditions of high performance liquid chromatography used are as follows.
Column: C18 column (manufactured by Shiseido Co., Ltd.)
Detection: UV310nm
Mobile phase: 72% ethanol / 10% acetonitrile / 17.5% ion-exchanged water / 0.5% acetic acid
各例の組成物を、アルミホイルで遮光して、50℃で1ヶ月保存した。1ヶ月(50℃)経過後の組成物中のビタミンA量を、高速液体クロマトグラフィーで分析し、製造直後のビタミンA量に対する残存率(%)を算出した。残存率が高いほどビタミンAの活性が維持され、しわ改善効果を発揮する。
使用した高速液体クロマトグラフィーの条件は以下の通りである。
カラム:C18カラム(株式会社資生堂製)
検出:UV310nm
移動相:72%エタノール/10%アセトニトリル/17.5%イオン交換水/0.5%酢酸 <Wrinkle improvement effect>
The compositions of each example were shielded from light with aluminum foil and stored at 50 ° C. for 1 month. The amount of vitamin A in the composition after 1 month (50 ° C.) was analyzed by high performance liquid chromatography, and the residual ratio (%) with respect to the amount of vitamin A immediately after production was calculated. The higher the residual rate, the more the activity of vitamin A is maintained and the effect of improving wrinkles is exhibited.
The conditions of high performance liquid chromatography used are as follows.
Column: C18 column (manufactured by Shiseido Co., Ltd.)
Detection: UV310nm
Mobile phase: 72% ethanol / 10% acetonitrile / 17.5% ion-exchanged water / 0.5% acetic acid
評価基準:
A:残存率が90%以上
B:残存率が80%以上かつ90%未満
C:残存率が60%以上かつ80%未満
D:残存率が60%未満 Evaluation criteria:
A: Residual rate is 90% or more B: Residual rate is 80% or more and less than 90% C: Residual rate is 60% or more and less than 80% D: Residual rate is less than 60%
A:残存率が90%以上
B:残存率が80%以上かつ90%未満
C:残存率が60%以上かつ80%未満
D:残存率が60%未満 Evaluation criteria:
A: Residual rate is 90% or more B: Residual rate is 80% or more and less than 90% C: Residual rate is 60% or more and less than 80% D: Residual rate is less than 60%
表1及び表2に示すように、粉末を第1の油相に配合し、ビタミンAを第2の油相に配合した本発明の組成物(実施例1~5)は、乳化安定性、肌補正効果、及びしわ改善効果の全てにおいて良好な結果が得られた。これらの良好な結果は、水相に配合する増粘剤の種類や配合量、あるいはシリコーンエラストマー粉末の有無に依らず(実施例1~3)、第2の油相におけるビタミンAの増量(実施例4)あるいは第1の油相における油分の種類(実施例5)にも依らない。一方、第2の油相における極性油の割合を低くすると、しわ改善効果が若干低下したが実用上問題のないレベルであった(実施例6)。実施例6の組成物は、50℃で1ヶ月保存するという厳しい条件下では分離がみられたが、実使用温度(室温)での保存では1ヶ月を超えて安定であった。
これらの実施例に対して、粉末を配合しない比較例1は、当然のことながら肌補正効果が得られなかった。また、粉末とビタミンAを同一の油相に配合した比較例2は、ビタミンAを安定に保持することができず、十分なしわ改善効果が得られなかった。 As shown in Tables 1 and 2, the compositions of the present invention (Examples 1 to 5) in which the powder was blended in the first oil phase and vitamin A was blended in the second oil phase had emulsion stability. Good results were obtained in all of the skin correction effect and the wrinkle improvement effect. These good results show that the amount of vitamin A in the second oil phase is increased (implementation) regardless of the type and amount of the thickener to be blended in the aqueous phase, or the presence or absence of the silicone elastomer powder (Examples 1 to 3). It does not depend on Example 4) or the type of oil in the first oil phase (Example 5). On the other hand, when the ratio of the polar oil in the second oil phase was lowered, the wrinkle improving effect was slightly reduced, but there was no problem in practical use (Example 6). The composition of Example 6 was separated under severe conditions of storage at 50 ° C. for 1 month, but was stable for more than 1 month when stored at the actual operating temperature (room temperature).
As a matter of course, the skin correction effect was not obtained in Comparative Example 1 in which the powder was not blended with respect to these Examples. Further, in Comparative Example 2 in which the powder and vitamin A were blended in the same oil phase, vitamin A could not be stably retained, and a sufficient wrinkle improving effect could not be obtained.
これらの実施例に対して、粉末を配合しない比較例1は、当然のことながら肌補正効果が得られなかった。また、粉末とビタミンAを同一の油相に配合した比較例2は、ビタミンAを安定に保持することができず、十分なしわ改善効果が得られなかった。 As shown in Tables 1 and 2, the compositions of the present invention (Examples 1 to 5) in which the powder was blended in the first oil phase and vitamin A was blended in the second oil phase had emulsion stability. Good results were obtained in all of the skin correction effect and the wrinkle improvement effect. These good results show that the amount of vitamin A in the second oil phase is increased (implementation) regardless of the type and amount of the thickener to be blended in the aqueous phase, or the presence or absence of the silicone elastomer powder (Examples 1 to 3). It does not depend on Example 4) or the type of oil in the first oil phase (Example 5). On the other hand, when the ratio of the polar oil in the second oil phase was lowered, the wrinkle improving effect was slightly reduced, but there was no problem in practical use (Example 6). The composition of Example 6 was separated under severe conditions of storage at 50 ° C. for 1 month, but was stable for more than 1 month when stored at the actual operating temperature (room temperature).
As a matter of course, the skin correction effect was not obtained in Comparative Example 1 in which the powder was not blended with respect to these Examples. Further, in Comparative Example 2 in which the powder and vitamin A were blended in the same oil phase, vitamin A could not be stably retained, and a sufficient wrinkle improving effect could not be obtained.
Claims (10)
- 水相中に油相が分散した水中油型乳化組成物であって、前記油相が、粉末を含む第1の油相と、ビタミンA及び/又はその誘導体及び極性油を含む第2の油相とを含むことを特徴とする、水中油型乳化組成物。 An oil-in-water emulsified composition in which an oil phase is dispersed in an aqueous phase, wherein the oil phase contains a first oil phase containing powder and a second oil containing vitamin A and / or a derivative thereof and a polar oil. An oil-in-water emulsified composition comprising a phase.
- 前記第1の油相が非極性油を含む、請求項1に記載の水中油型乳化組成物。 The oil-in-water emulsified composition according to claim 1, wherein the first oil phase contains a non-polar oil.
- 前記非極性油がシリコーン油を含む、請求項2に記載の水中油型乳化組成物。 The oil-in-water emulsified composition according to claim 2, wherein the non-polar oil contains a silicone oil.
- 前記第2の油相が、組成物全量に対して0.01質量%以上のビタミンA及び/又はその誘導体を含む、請求項1から3のいずれか一項に記載の水中油型乳化組成物。 The oil-in-water emulsified composition according to any one of claims 1 to 3, wherein the second oil phase contains 0.01% by mass or more of vitamin A and / or a derivative thereof based on the total amount of the composition. ..
- 前記第2の油相が、組成物全量に対して1~35質量%の極性油を含む請求項1から4に記載の水中油型乳化組成物。 The oil-in-water emulsified composition according to claims 1 to 4, wherein the second oil phase contains 1 to 35% by mass of polar oil with respect to the total amount of the composition.
- 前記第2の油相が、第2の油相全量に対して15質量%以上の極性油を含有する、請求項1から5のいずれか一項に記載の水中油型乳化組成物。 The oil-in-water emulsified composition according to any one of claims 1 to 5, wherein the second oil phase contains 15% by mass or more of polar oil with respect to the total amount of the second oil phase.
- 前記極性油が紫外線吸収剤を含む、請求項1から6のいずれか一項に記載の水中油型乳化組成物。 The oil-in-water emulsified composition according to any one of claims 1 to 6, wherein the polar oil contains an ultraviolet absorber.
- 前記第2の油相が、高級アルコール及び/又は高級脂肪酸を含む、請求項1から7のいずれか一項に記載の水中油型乳化組成物。 The oil-in-water emulsified composition according to any one of claims 1 to 7, wherein the second oil phase contains a higher alcohol and / or a higher fatty acid.
- 水相が、ポリオキシエチレン硬化ヒマシ油、ステアリン酸ポリオキシエチレングリセリル、イソステアリン酸ポリオキシエチレングリセリル、トリイソステアリン酸ポリオキシエチレングリセリル、ポリオキシエチレン硬化ヒマシ油コハク酸からなる群から選択される少なくとも1種の非イオン性界面活性剤を含む、請求項1から8のいずれか一項に記載の水中油型乳化組成物。 At least one aqueous phase selected from the group consisting of polyoxyethylene hydrogenated castor oil, polyoxyethylene glyceryl stearate, polyoxyethylene glyceryl isostearate, polyoxyethylene glyceryl triisostearate, polyoxyethylene hydrogenated castor oil succinic acid. The oil-in-water emulsified composition according to any one of claims 1 to 8, which comprises a nonionic surfactant of the species.
- 請求項1から9のいずれか一項に記載の水中油型乳化組成物からなる水中油型乳化化粧料。 An oil-in-water emulsified cosmetic comprising the oil-in-water emulsified composition according to any one of claims 1 to 9.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202180026591.8A CN115379822B (en) | 2020-05-01 | 2021-04-30 | Oil-in-water emulsion composition |
JP2022518143A JPWO2021221149A1 (en) | 2020-05-01 | 2021-04-30 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020081091 | 2020-05-01 | ||
JP2020-081091 | 2020-05-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021221149A1 true WO2021221149A1 (en) | 2021-11-04 |
Family
ID=78332024
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2021/017143 WO2021221149A1 (en) | 2020-05-01 | 2021-04-30 | Oil-in-water emulsion composition |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2021221149A1 (en) |
CN (1) | CN115379822B (en) |
WO (1) | WO2021221149A1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11244688A (en) * | 1998-02-27 | 1999-09-14 | Shiseido Co Ltd | Oil in water emulsion composition |
JP2007186471A (en) * | 2006-01-16 | 2007-07-26 | Shiseido Co Ltd | Promoter of type i collagen production and anti-wrinkle agent |
JP2013193999A (en) * | 2012-03-21 | 2013-09-30 | Shiseido Co Ltd | Oil-in-water type emulsion cosmetic |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9833391B2 (en) * | 2009-03-20 | 2017-12-05 | The Proctor & Gamble Company | Personal-care composition comprising a hydrocarbon wax and a polar oil |
-
2021
- 2021-04-30 WO PCT/JP2021/017143 patent/WO2021221149A1/en active Application Filing
- 2021-04-30 CN CN202180026591.8A patent/CN115379822B/en active Active
- 2021-04-30 JP JP2022518143A patent/JPWO2021221149A1/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11244688A (en) * | 1998-02-27 | 1999-09-14 | Shiseido Co Ltd | Oil in water emulsion composition |
JP2007186471A (en) * | 2006-01-16 | 2007-07-26 | Shiseido Co Ltd | Promoter of type i collagen production and anti-wrinkle agent |
JP2013193999A (en) * | 2012-03-21 | 2013-09-30 | Shiseido Co Ltd | Oil-in-water type emulsion cosmetic |
Non-Patent Citations (1)
Title |
---|
DATABASE GNPD 21 October 2014 (2014-10-21), ANONYMOUS: "CC Cream SPF 25/PA++, ID 2737721", XP055863013, retrieved from Mintel Database accession no. 2737721 * |
Also Published As
Publication number | Publication date |
---|---|
CN115379822A (en) | 2022-11-22 |
CN115379822B (en) | 2024-08-23 |
JPWO2021221149A1 (en) | 2021-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5352116B2 (en) | Oil-in-water emulsion composition and method for producing the same | |
JP5053887B2 (en) | Oil-in-water emulsion composition | |
JP5814117B2 (en) | W / O emulsified cosmetic | |
JP6878462B2 (en) | Underwater oil type emulsified cosmetic | |
JP6927956B2 (en) | Aqueous cosmetic composition | |
WO2011077779A1 (en) | Sheet-like cosmetic | |
JP2010120857A (en) | Skin external preparation | |
WO2020067420A1 (en) | Water-in-oil emulsified solid cosmetic | |
JP6359295B2 (en) | Water-in-oil emulsified cosmetic and method for producing the same | |
JP7347993B2 (en) | sunscreen composition | |
JP6741836B2 (en) | Oil-in-water emulsion cosmetic | |
JP2024107425A (en) | Cosmetics | |
JPH11279021A (en) | Oil-in-water type emulsified composition | |
JP7373264B2 (en) | sunscreen cosmetics | |
WO2021132018A1 (en) | Oily particle and external composition | |
JP2004269418A (en) | Cosmetic | |
JP6831737B2 (en) | Underwater oil type cosmetics | |
JP7370820B2 (en) | oil-in-water composition | |
WO2021221149A1 (en) | Oil-in-water emulsion composition | |
JP2021107372A (en) | Oily composition | |
CN112996473A (en) | Powder dispersion composition and dispersion method thereof | |
JP7445425B2 (en) | oily composition | |
JP7522736B2 (en) | Oil-in-water emulsion cosmetics | |
WO2022137637A1 (en) | Oil-in-water-type emulsified cosmetic material | |
WO2020195549A1 (en) | Sunscreen cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21795512 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2022518143 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21795512 Country of ref document: EP Kind code of ref document: A1 |